Noble Capital Markets analyst Joe Gomes downgrades Lifeway Foods (NASDAQ:LWAY) from Outperform to Market Perform.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/24/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 5/30/2024 | $20.00 | Market Perform → Outperform | Noble Capital Markets |
| 4/5/2024 | $25.00 | Buy | Lake Street |
| 3/27/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 2/26/2024 | $14.00 | Market Perform → Outperform | Noble Capital Markets |
| 11/27/2023 | Outperform → Market Perform | Noble Capital Markets | |
| 11/14/2023 | $13.00 | Market Perform → Outperform | Noble Capital Markets |
| 9/25/2023 | Outperform → Market Perform | Noble Capital Markets |
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
8-A12B - Lifeway Foods, Inc. (0000814586) (Filer)
10-Q - Lifeway Foods, Inc. (0000814586) (Filer)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
MORTON GROVE, Ill., Nov. 8, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2024 on November 14, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sectio
CHICAGO, Nov. 7, 2024 /PRNewswire/ -- On September 23, 2024, Danone SA (OTCQX:DANOY) proposed to acquire Lifeway Foods (NASDAQ:LWAY) in a transaction valued at approximately $283 million, offering $25 per share in cash. However, on November 6, the Lifeway Foods Board of Directors rejected the offer, instead adopting a "poison pill" limited shareholder rights plan. Edward and Ludmila Smolyansky, significant shareholders and members of Lifeway Foods' founding family, released the following statement in response: "For nearly four decades, we have fostered Lifeway's growth with careful attention to what is best for the company's future. Today, we strongly support Danone's offer, which represent
Lifeway CEO Julie Smolyansky announces substantial new distribution during Gulfood Manufacturing exhibition DUBAI, UAE, Nov. 7, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. manufacturer of kefir and fermented probiotic products, announced today an expanded distribution agreement in the United Arab Emirates market. The offering of 32oz Lifeway Kefir, 8oz Lactose-Free Lifeway Kefir, ProBugs and farmer cheese, exported from the United States, is expected to begin shipping in the fourth quarter of 2024 and will become available in supermarkets and hypermarkets in Dubai and across the Emirates. The announcement was made by Lifeway President a
Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that the Company has been included in the Russell 2000® and Russell 3000® Indexes, as part of the annual reconstitution of the Russell stock indexes, effective at the open of U.S. equity markets on July 1, 2024.
MORTON GROVE, Ill., Nov. 8, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2024 on November 14, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sectio
MORTON GROVE, Ill., Nov. 5, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has rejected the unsolicited proposal made on September 23, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $25.00 per share. After careful and thorough consideration, conducted in consultation with its independent financial and legal advisors, the Boar
Demand for Bioavailable Foods like Kefir Soars Net sales of $49.2 million; up 25.3% year-over-year driven by volume growth of Lifeway Kefir 19th consecutive quarter of year-over-year growth MORTON GROVE, Ill., Aug. 13, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the second quarter ended June 30, 2024. "Our incredible momentum continued in the second quarter as we delivered our 19th consecutive quarter of net
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00
Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00